Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 46,964 shares, an increase of 2,398.1% from the June 15th total of 1,880 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 83,081 shares, the short-interest ratio is presently 0.6 days.
Straumann Stock Performance
Shares of SAUHY traded up $0.18 during trading hours on Friday, hitting $13.03. The stock had a trading volume of 78,950 shares, compared to its average volume of 37,098. Straumann has a 1-year low of $9.44 and a 1-year high of $14.11. The firm has a 50 day simple moving average of $11.97 and a 200-day simple moving average of $11.65.
Analysts Set New Price Targets
SAUHY has been the subject of several analyst reports. Barclays reiterated an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. BMO Capital Markets began coverage on shares of Straumann in a research note on Wednesday. They issued an “outperform” rating for the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Straumann in a research note on Tuesday, June 30th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold”.
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Read More
- Five stocks we like better than Straumann
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
